Log In
BCIQ
Print this Print this
 

GTx-230

  Manage Alerts
Collapse Summary General Information
Company GTx Inc.
DescriptionTubulin antagonist
Molecular Target Tubulin
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard Indication Cancer (unspecified)
Indication DetailsTreat cancer
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today